August 27. 2018
Tampa company focused on cancer treatment launches first human clinical study
By Margie Manning – Finance Editor, Tampa Bay Business Journal
Morphogenesis Inc. is launching its first human clinical study for the treatment of skin cancer.
It’s an important benchmark for the Tampa company, which raised $16 million earlier this year in a Series A investment round led by entrepreneur and philanthropist Dr. Kiran Patel.
The Phase 1 study is “the biggest milestone so far” for Morphogenesis, said CEO Patricia Lawman…
May 9. 2018
Tampa Company To Begin Clinical Trials On Promising Cancer Therapy
WUSF Public Media-Health News Florida;
Morphogenesis, Inc. will begin the trials on six patients with an aggressive form of skin cancer at Moffitt Cancer Center this summer.
May 2 & 3, 2018
Latest Media Articles
Articles posted by both the Tampa Bay Business Journal and BioFlorida’s BioPulse Publication can be accessed below;
Tampa Bay Business Journal:
Why Kiran Patel is backing a Tampa company developing cancer treatments
New HQ puts Tampa immunotherapy company in Moffitt’s backyard
BioFlorida’s BioPulse Publication:
Morphogenesis, Inc Raises $16 Million To Advance Into Human Clinical Trials
July 28, 2016
Greenville Online-Part of the USA Today Network: Cancer vaccine used on dogs may one day help their owners
Liv Osby, losby@gannett.com
Greenville, North Carolina. Ingrid and Ben Herrmann-Holmes love their dogs and tend to adopt older ones, like their three elderly basset hounds — one who needs a wheelchair. So when their 13-year-old Blue Tick Coonhound began limping on his left front leg, they took him to the vet right away. The news wasn’t good.
June 29, 2016
Coverage of the Morphogenesis hosting of the Vice President’s Cancer Moonshot Summit
Live coverage of the event by Dr. Joette Giovinco from Fox 13 News can be viewed through Facebook. In addition, coverage by Fox 13 News, NBC News Channel 8 and CBS 10 News can be viewed by clicking on the images below;
